{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:30:14Z","timestamp":1786735814012,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Res Pharma Sci"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/1735-5362.268201","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T01:18:54Z","timestamp":1569806334000},"page":"408","source":"Crossref","is-referenced-by-count":21,"title":["Synthesis and cytotoxic evaluation of some quinazolinone- 5-(4-chlorophenyl) 1, 3, 4-oxadiazole conjugates"],"prefix":"10.4103","volume":"14","author":[{"given":"Elham","family":"Jafari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshid","family":"Hassanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojjat","family":"Sadeghi-Aliabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Sharifzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1735-5362.268201-1","first-page":"203","article-title":"Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4- (trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents.Eur J Med Chem","author":"Puthiyapurayil","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-2","first-page":"1474","article-title":"Various approaches for synthesis 3, 4-oxadiazole derivative and their pharmacological activity.World J Pharm Pharm Sci","author":"Singh","year":"2014","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-3","unstructured":"Siddiqui SZ, Rehman A, Abbasi MA, Abbas N, Khan KM, Ashraf M, et al. Synthesis, characterization and biological screening of N-substituted derivatives of 5- benzyl-1,3,4-oxadiazole-2yl-2\u2019'-sulfanyl acetamide. Pak J Pharm. Sci. 2013;26(3):455-463."},{"key":"key-10.4103\/1735-5362.268201-4","first-page":"330","article-title":"Synthesis and antimicrobial evaluation of some 2,5 disubstituted 1,3,4-oxadiazole derivatives.Res Pharm Sci","author":"Jafari","year":"2017","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-5","first-page":"502","article-title":"Synthesis and anticancer evaluation of some novel 3-[5-(4-Substituted) Phenyl1,3,4- oxadiazole2yl-]-2-phenylquinazoline4(3H)-ones.Int J Pharm Pharm Sci","author":"Kumar","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-6","first-page":"10192","article-title":"Synthetic approaches and pharmacological activity of 1,3,4-oxadiazoles: a review of the literature from 2000-2012.Molecules","author":"de","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-7","first-page":"140","article-title":"Biological importance of 1, 3, 4- oxadiazole derivatives.IJABR","author":"Singh","year":"2013","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-8","first-page":"151","article-title":"One-pot, four- component synthesis of novel cytotoxic agents1-(5- aryl-1,3,4-oxadiazol-2-yl)-1-(1 H-pyrrol-2- yl)methanamines.Eur J Med Chem","author":"Ramazani","year":"2014","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-9","first-page":"2327","article-title":"Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.Eur J Med Chem","author":"Noolvi","year":"2011","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-10","first-page":"49","article-title":"Recent advances of quinazolinone derivatives as marker for various biological activities.Int Res J Pharm","author":"Chawla","year":"2013","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-11","first-page":"151","article-title":"Antibacterial, antifungal and cytotoxic evaluation of some new 2, 3- disubstituted 4(3H)-quinazolinone derivatives.Res Pharm Sci","author":"Khodarahmi","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-12","first-page":"789","article-title":"Synthesis of some new quinazolinone derivatives and evaluation of their antimicrobial activities.Iran J Pharm Res","author":"Khodarahmi","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-13","first-page":"213","article-title":"Synthesis, antimicrobial evaluation and docking studies of some novel quinazolinone Schiff base derivatives.Res Pharm Sci","author":"Rezaee","year":"2018","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-14","first-page":"1","article-title":"Quinazolinone and quinazoline derivatives: recent structures with potent antimicrobial and cytotoxic activities.Res Pharm Sci","author":"Jafari","year":"2016","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-15","first-page":"76","article-title":"Cytotoxic evaluation of some fused pyridazino- and pyrrolo- quinazolinones derivatives on melanoma and prostate cell lines.Adv Biomed Res","author":"Vaseghi","year":"2017","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-16","first-page":"212","article-title":"Synthesis and evaluation of some novel 3-[5-phenyl- 1,3,4-oxadiazole-2-yl]-2(substitutedstyryl)- quinazoline-4(3H)-ones for antibacterial activity.J Chem Pharm Res","author":"Sowjanya","year":"2011","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-17","first-page":"1207","article-title":"Synthesis and anti-denaturation activity of some substituted quinazolinone analogs.Int J Chem Tech Res","author":"Rajasekaran","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-18","first-page":"470","article-title":"Synthesis, antibacterial and antioxidant activity of some 2, 3-susbtituted quinazolin-4(3H)-ones.Der Pharmacia Lett","author":"Rajasekaran","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-19","first-page":"19914","article-title":"Synthesis, molecular modeling, and biological evaluation of quinazoline derivatives containing the 1,3,4-oxadiazole scaffold as novel inhibitors of VEGFR.RSC Adv","author":"Qiao","year":"2015","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-20","first-page":"30","article-title":"Analgesic activity of 3-[(5-substitued) - 1, 3, 4 oxadiazole-2-yl) methylamino]-2-methyl quinazolin- 4(3h)-ones.Int J Anal Pharm Biomed Sci","author":"Dhani","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-21","first-page":"1","article-title":"Design and synthesis of quinazolinyl acetamide for their analgesic and anti-inflammatory activities.Z Naturforsch","author":"Alagarsamy","year":"2015","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-22","first-page":"130","article-title":"Synthesis and cytotoxic evaluation of some derivatives of triazole-quinazolinone hybrids.Res Pharm Sci","author":"Hassanzadeh","year":"2019","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-23","first-page":"93","article-title":"Synthesis of some new tricyclic 4(3H)- quinazolinone derivatives.Res Pharm Sci","author":"Jafari","year":"2011","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-24","first-page":"124","article-title":"1,3,4-Oxadiazoles: an emerging scaffold to target growth factors,enzymes and kinases as anticancer agents.Eur J Med Chem","author":"Bajaj","year":"2015","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-25","first-page":"1191","article-title":"Oxadiazole derivatives as a novel class of antimitotic agents: Synthesis, inhibition of tubulin polymerization, and activity in tumor cell line.Bioorg Med Chem Lett","author":"Ouyang","year":"2006","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-26","first-page":"6518","article-title":"Synthesis, biological evaluation, and molecular docking studies of 1, 3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.Bioorg Med Chem","author":"Zhang","year":"2011","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-27","doi-asserted-by":"crossref","unstructured":"Tiwari AK. Singh VK, Bajpai A, Shukla G, Singh S, Mishra AK. Synthesis and biological properties of 4-(3H)-quinazolone derivatives. Eur J Med Chem. 2007;42(9):1234-1238.","DOI":"10.1016\/j.ejmech.2007.01.002"},{"key":"key-10.4103\/1735-5362.268201-28","first-page":"659","article-title":"Synthesis, characterization, and biological evaluation of new quinazolin-4-one derivatives hybridized with pyridine or pyran moiety.Res Chem Inter med","author":"Ahmed","year":"2016","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-29","first-page":"247","article-title":"Development of certain new 2-substituted-quinazolin-4- ylaminobenzenesulfonamide as potential antitumor agents.Eur J Med Chem","author":"Alafeefy","year":"2016","journal-title":""},{"key":"key-10.4103\/1735-5362.268201-30","first-page":"247","article-title":"Synthesis and cytotoxic evaluation of novel quinozalinone derivatives with substituted benzimidazole in position 3","author":"Taherian","year":"2019","journal-title":"Res Pharm Sci,"}],"container-title":["Research in Pharmaceutical Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:33:55Z","timestamp":1786732435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1735-5362.268201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"alternative-id":["268201"],"URL":"https:\/\/doi.org\/10.4103\/1735-5362.268201","relation":{},"ISSN":["1735-5362"],"issn-type":[{"value":"1735-5362","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}